Charles W. Lynde
Peterborough, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 226 publications
Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical Trials.
Journal: Dermatology and therapy
Published: May 07, 2026
Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry.
Journal: Dermatology and therapy
Published: April 20, 2026
A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics.
Journal: Frontiers in medicine
Published: April 02, 2026
Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma.
Journal: Clinical and experimental dermatology
Published: April 01, 2026
Disease Burden in a Cohort of Canadian Adults With Moderate-to-Severe Atopic Dermatitis by Systemic Therapy Use.
Journal: Journal of cutaneous medicine and surgery
Published: March 26, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment Paradigms.
Journal: Journal of cutaneous medicine and surgery
Published: March 19, 2026
Evaluation of Injection Site Pain and Adherence in Patients Transitioning from a High to Low Volume Adalimumab Formulation (AVT02, Simlandi®) Across Multiple Indications (EASE PAIN).
Journal: Rheumatology and therapy
Published: February 18, 2026
INDIVIDUAL ARTICLE: NECOM 7: Real-World Cases on Preventive and Treatment Using Skin Care for Cancer Treatment-Related Skin Reactions.
Journal: Journal of drugs in dermatology : JDD
Published: December 02, 2025
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites.
Journal: NEJM evidence
Published: November 05, 2025
Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies.
Journal: Dermatology and therapy
Published: October 25, 2025
A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study.
Journal: Dermatology and therapy
Published: September 27, 2025
Last Updated: 09/26/2026